ABO(H) and Lewis blood group substances and disease treatment

被引:3
|
作者
Liu, Junting [1 ]
Wang, Deqing [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Transfus Med, 301 Hosp,28 Fuxing Rd, Beijing 100853, Peoples R China
关键词
antibody; antigen; blood group; disease treatment; INCOMPATIBLE KIDNEY-TRANSPLANTATIONS; ANTIGEN-SPECIFIC IMMUNOADSORPTION; MONOCLONAL-ANTIBODY HU3S193; HELICOBACTER-PYLORI; NOROVIRUS INFECTION; DOWN-REGULATION; OVARIAN-CANCER; LEY ANTIBODY; LUNG-CANCER; Y LE(Y);
D O I
10.1111/tme.12820
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since the early 20th century, scientists have determined that blood group antigens can be inherited. With more and more studies have been devoted to finding the relationship between blood groups and diseases, the relationship of ABO(H) and Lewis blood groups and the development of human diseases have been summarised. In addition, many studies have shown that blood group substances, such as blood group antigen or related antibody, play an important role in disease prevention and treatment. This review focuses on the advances of ABO(H), Lewis blood group substances in the treatment of diseases, which has important significance for the development of novel therapeutic methods.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 50 条